Vicat (VCT) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
16 Jan, 2026Executive summary
Organic sales grew 3.3% over nine months, with strong US gains and resilience in emerging markets offsetting weak European residential and Asian markets.
Strategic combination with Koramic/VPI+Cermix created a French leader in construction chemicals with €200 million annual sales, 60% owned by the group.
2024 EBITDA growth guidance confirmed at 3%-8%, with leverage ratio targeted below 1.7x by year-end.
Financial highlights
Nine-month 2024 sales: €2,916 million, down 1.5% reported, up 3.3% like-for-like; Q3 sales: €979 million, down 6.6% reported, up 0.7% like-for-like.
Currency effects, notably from Turkish lira, Egyptian pound, and Brazilian real, negatively impacted sales by €73 million in Q3.
U.S. sales now represent 19% of group sales, up 1.3 percentage points year-over-year.
Italy posted 12% sales growth, while France and Switzerland saw volume declines but stable prices.
Cement volumes for nine months: 21,312 thousand tonnes, down 1.0% year-over-year.
Outlook and guidance
2024 EBITDA growth target confirmed at 3%-8%, with leverage ratio targeted below 1.7x by year-end and below 1.3x by end-2025.
CapEx for 2024 expected at ~€325 million, with significant decrease planned for 2025.
Priorities: restore EBITDA margin above pre-crisis level (19.8% in 2021), deleverage, and execute the climate roadmap.
U.S. expected to see further growth in 2025, with European residential market stabilizing and Senegal kiln ramp-up boosting H2 Africa performance.
Latest events from Vicat
- Sales +3.3% LFL, EBITDA +3.7% LFL, strong cash flow, and major decarbonization progress.VCT
H2 202517 Feb 2026 - EBITDA up 12.3% and organic sales up 4.8% in H1 2024, led by US and emerging markets.VCT
H1 20242 Feb 2026 - Stable Q1 2025 sales and confirmed guidance, with growth expected from new projects.VCT
Q1 2025 TU24 Dec 2025 - Record EBITDA and cash flow, with US growth and climate progress offsetting European weakness.VCT
H2 202410 Dec 2025 - Q3 2025 saw 4.9% organic sales growth and strategic progress despite FX headwinds.VCT
Q3 2025 TU13 Nov 2025 - Stable sales and improved net income, with 2025 EBITDA growth guided at +2–5% like-for-like.VCT
H1 202520 Oct 2025